Sign in

CIK 0001674416 · Large accelerated filer

CRISPR Therapeutics AG

Sign in to watch
Ticker
CRSP
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
Switzerland
Entity type
operating
EIN
473173478
Phone
6173154600
Business address
BAARERSTRASSE 14, ZUG, Switzerland
Former names
CRISPR Therapeutics AG
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$4,881,673
in 7 filings, $1.5M under 10b5-1 plans

Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Kulkarni Samarth −$2.6M Chief Executive Officer sold 14% of stake
  2. KASINGER JAMES R. −$797K General Counsel and Secretary sold 12% of stake
  3. Behbahani Ali −$781K Director sold 45% of stake
  4. George Simeon −$720K Director sold 48% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-12-06 Ho Tony W Executive VP, Head of R&D Shares withheld for taxes −12,607 $69.17 $872K 52,364
2021-12-06 KASINGER JAMES R. General Counsel and Secretary Shares withheld for taxes −6,303 $69.17 $436K 43,542
2021-12-03 Kulkarni Samarth Chief Executive Officer Option exercise +80,000 299,153
2021-12-03 Kulkarni Samarth Chief Executive Officer Option exercise · Restricted Stock Units +80,000 40,000
2021-12-03 Klein Lawrence Otto CBO & COO Option exercise +26,667 33,510
2021-12-03 Klein Lawrence Otto CBO & COO Option exercise · Restricted Stock Units +26,667 13,333
2021-12-03 Ho Tony W Executive VP, Head of R&D Option exercise +26,667 64,971
2021-12-03 Ho Tony W Executive VP, Head of R&D Option exercise · Restricted Stock Units +26,667 13,333
2021-12-03 KASINGER JAMES R. General Counsel and Secretary Option exercise +13,333 49,845
2021-12-03 KASINGER JAMES R. General Counsel and Secretary Option exercise · Restricted Stock Units +13,333 6,667
2021-12-02 KASINGER JAMES R. General Counsel and Secretary Option exercise +7,342 $13.62 $100K 36,512
2021-12-02 KASINGER JAMES R. General Counsel and Secretary Option exercise · Stock Option (Right to Buy) −7,342 93,632
2021-12-01 Kulkarni Samarth Chief Executive Officer Shares withheld for taxes −779 $75.10 $59K 219,153
2021-10-15 KASINGER JAMES R. General Counsel and Secretary Grant or award · Stock Option (Right to Buy) +10,800 10,800
2021-10-15 Klein Lawrence Otto CBO & COO Grant or award · Stock Option (Right to Buy) +13,800 13,800
2021-10-15 Kulkarni Samarth Chief Executive Officer Option exercise +33,000 $1.81 $60K 219,932
2021-10-15 Kulkarni Samarth Chief Executive Officer Grant or award · Stock Option (Right to Buy) +43,000 43,000
2021-10-15 Kulkarni Samarth Chief Executive Officer Option exercise · Stock Option (Right to Buy) −33,000 75,983
2021-10-15 Ho Tony W Executive VP, Head of R&D Grant or award · Stock Option (Right to Buy) +13,800 13,800
2021-10-14 Smith Brendan Chief Financial Officer Grant or award · Restricted Stock Units +15,000 15,000

Page 24 of 46 · 910 trades